A vaccine comprising a recombinant escherichia coli expressing and secreting an ltb-antigen fusion protein
AU2018338975A1
A universal platform for preparing an inhibitory chimeric antigen receptor (iCAR)
EP3672936A1
Compositions and methods for treating atherosclerotic cardiovascular disease
EP3665276A1
Improved endoinulinases
WO2019026067A1
Extracts of nannochloropsis microalgae and their uses
WO2018078626A1
Combination therapies including human chitinase (chit1) for the treatment of systemic fungal infection
BR112019006006A2
nucleic acid molecule, vector, methods for preparing a chimeric inhibitory antigen receptor, preparing a safe effector immune cell, selecting a custom biomarker, and treating cancer in a patient with a tumor, safe effector immune cell, and, combination of two or more nucleic acid molecules.
CN108431025A
Optimization polypeptide for anti-Avianreovirus subunit vaccine
EP3429967A1
Method for production of potable water
IL244020D0
Method for pretreatment of wastewater with nanocomposites and bridging polymers
EP3244905A1
Extracts of edible fungi enriched in vitamin d and compositions thereof and their use in the treatment of immune-related disorders
WO2015118541A1
A genetic system for generating conditionally inactivated or attenuated bacteria
GB201416495D0
A system for treatment of polluted effluents by photocatalysis
CA2927610A1
Method for pretreatment of wastewater and recreational water with nanocomposites and bridging polymers
WO2014054046A1
Ordered reversible fibrils, aggregates and multimers of proteins and uses thereof
WO2013030812A1
High-methionine transgenic soybean seeds expressing the arabidopsis cystathionine gamma-synthase gene
